Unlike gliomas where IDH1 R132H mutation is predominant and can be diagnosed by immunohistochemistry,33 the distribution of IDH1 mutations is more heterogeneous in chondrosarcoma with R132C being the most frequent followed by R132G and R132L. Here, IDH1 is linked to glioma.